Literature DB >> 27654105

Extent of Extrathyroidal Extension as a Significant Predictor of Nodal Metastasis and Extranodal Extension in Patients with Papillary Thyroid Carcinoma.

Ji Won Kim1, Jong-Lyel Roh2, Gyungyup Gong3, Kyung-Ja Cho3, Seung-Ho Choi1, Soon Yuhl Nam1, Sang Yoon Kim1.   

Abstract

BACKGROUND: Extrathyroidal extension (ETE) and extranodal extension (ENE) indicate poor prognosis for patients with papillary thyroid carcinoma (PTC). The relationships among ETE, ENE, and nodal metastasis (N1) have not been thoroughly studied. In this study, we examined the relationships among the extent of ETE, N1, ENE, and posttreatment recurrence in patients with PTC.
METHODS: This study enrolled 1693 consecutive patients with previously untreated PTC who underwent thyroidectomy between 2006 and 2009. The extent of ETE was graded based on intraoperative and pathological findings, and central and lateral neck (N1b) nodal metastases and ENE were pathologically determined. Univariate and multivariate analyses were used to identify the association of clinicopathological factors with recurrence-free survival (RFS) and to define the relationships among the extent of ETE, N1, and ENE.
RESULTS: Of 1693 patients, 1087 (64.2 %) had ETE and 201 (11.9 %) had ENE. Pathologically positive lymph nodes were found in 783 patients (46.2 %), of whom 236 (30.1 %) had N1b. During the median follow-up of 86 months, 90 (5.3 %) patients had recurrences. Multivariate analyses showed that multifocality, ETE, T and N classification, the risk of structural recurrence proposed by the American Thyroid Association, and ENE were independent variables for RFS (P < .05). Patients with macroscopic ETE had a 13-fold increased risk of recurrence, and ETE had significant relationships with N1, N1b, and ENE (all P < .001).
CONCLUSIONS: Local extension, nodal involvement, and ENE contribute to posttreatment recurrence of PTC. Macroscopic ETE predicts nodal metastasis and ENE, which are adverse pathologic features.

Entities:  

Mesh:

Year:  2016        PMID: 27654105     DOI: 10.1245/s10434-016-5594-4

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  16 in total

Review 1.  Crucial parameters in thyroid carcinoma reporting - challenges, controversies and clinical implications.

Authors:  Bin Xu; Ronald A Ghossein
Journal:  Histopathology       Date:  2018-01       Impact factor: 5.087

2.  Factors Influencing Cervical Lymph Node Metastasis in Pediatric Differentiated Thyroid Cancers.

Authors:  Sajid S Qureshi; Mufaddal Kazi; Jarin Noronha; Vasundhara Smriti; Sandeep Basu; Sneha Shah; Sanjay Talole
Journal:  Indian J Surg Oncol       Date:  2021-03-25

3.  Male patients with papillary thyroid cancer have a higher risk of extranodal extension.

Authors:  Hu Hei; Bin Zhou; Wenbo Gong; Chen Zheng; Jianwu Qin
Journal:  Int J Clin Oncol       Date:  2022-01-08       Impact factor: 3.402

4.  Nomogram Including Elastography for Prediction of Contralateral Central Lymph Node Metastasis in Solitary Papillary Thyroid Carcinoma Preoperatively.

Authors:  Ning Li; Ju-Hua He; Chao Song; Li-Chun Yang; Hong-Jiang Zhang; Zhi-Hai Li
Journal:  Cancer Manag Res       Date:  2020-10-29       Impact factor: 3.989

5.  Does macroscopic extrathyroidal extension to the strap muscles alone affect survival in papillary thyroid carcinoma?

Authors:  Victoria Harries; Marlena McGill; Avery Yuan; Laura Y Wang; R Michael Tuttle; Ashok R Shaha; Jatin P Shah; Richard J Wong; Snehal G Patel; Ian Ganly
Journal:  Surgery       Date:  2021-09-30       Impact factor: 4.348

6.  PTC located in the upper pole is more prone to lateral lymph node metastasis and skip metastasis.

Authors:  Yi Dou; Daixing Hu; Yingji Chen; Wei Xiong; Qi Xiao; Xinliang Su
Journal:  World J Surg Oncol       Date:  2020-07-28       Impact factor: 2.754

7.  Predictive factors of lateral lymph node metastasis in conventional papillary thyroid carcinoma.

Authors:  Muye Song; Ziyang Huang; Shujie Wang; Jianhao Huang; Hongyan Shi; Yongchen Liu; Yijie Huang; Ying Yin; Zeyu Wu
Journal:  Gland Surg       Date:  2020-08

Review 8.  Data set for reporting carcinoma of the thyroid: recommendations from the International Collaboration on Cancer Reporting.

Authors:  Ronald Ghossein; Justine A Barletta; Martin Bullock; Sarah J Johnson; Kennichi Kakudo; Alfred K Lam; Mufaddal T Moonim; David N Poller; Giovanni Tallini; R Michael Tuttle; Bin Xu; Anthony J Gill
Journal:  Hum Pathol       Date:  2020-09-10       Impact factor: 3.466

9.  Significance of distance between tumor and thyroid capsule as an indicator for central lymph node metastasis in clinically node negative papillary thyroid carcinoma patients.

Authors:  Chan Yong Seong; Young Jun Chai; Sang Mok Lee; Su-Jin Kim; June Young Choi; Kyu Eun Lee; Ki-Tae Hwang; Sun-Won Park; Ka Hee Yi
Journal:  PLoS One       Date:  2018-07-17       Impact factor: 3.240

10.  Unnecessity of Routine Dissection of Right Central Lymph Nodes in cN0 Papillary Thyroid Carcinoma Located at the Left Thyroid Lobe.

Authors:  Songtao Zhang; Runfang Zhang; Chao Wang; Wenbo Gong; Chen Zheng; Qigen Fang; Liyuan Dai
Journal:  Front Oncol       Date:  2021-07-01       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.